Skip to content

Glenmark Pharma gets approval from Health Canada for nasal spray Ryaltris

Health Canada granted approval to partner Bausch Health Companies Inc and Glenmark Specialty SA, a subsidiary of the company, for Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray), Glenmark Pharmaceuticals said in a statement.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish